Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mahdy

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Computational Biology and Chemistry|September 27, 2024
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studiesHazem Elkady, Walid E Elgammal, Hazem A Mahdy, et al.
RSC Advances|November 7, 2024
Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive <i>in vitro</i> and <i>in silico</i> studyIbrahim H Eissa, Walid E Elgammal, Hazem A Mahdy, et al.
Chemical Biology & Drug Design|March 26, 2026
Thiadiazole-Derived VEGFR-2 Inhibitors: From Design to Anticancer EvaluationAisha A Alsfouk, Eslam B Elkaeed, Hazem Elkady, et al.
Environmental Pollution (Barking, Essex : 1987)|October 11, 2016
Infectious bacterial pathogens, parasites and pathological correlations of sewage pollution as an important threat to farmed fishes in EgyptMahmoud A Mahmoud, Mohamed Abdelsalam, Olfat A Mahdy, et al.
Chemical Biology & Drug Design|July 21, 2025
New Thiadiazole-Benzenesulfonamide Hybrids as Dual B-Raf/VEGFR-2 Inhibitors With Promising Anti-Hepatic Cancer ActivityAisha A Alsfouk, Hazem Elkady, Saber M Hassan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 28, 2021
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studiesHazem Elkady, Alaa Elwan, Hesham A El-Mahdy, et al.
Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
International Journal of Molecular Sciences|August 12, 2023
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide AnalogsReda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy, et al.
Plants (Basel, Switzerland)|February 26, 2022
Improvement of Selected Morphological, Physiological, and Biochemical Parameters of Roselle (<i>Hibiscus sabdariffa</i> L.) Grown under Different Salinity Levels Using Potassium Silicate and <i>Aloe saponaria</i> ExtractAlaa Idris Badawy Abou-Sreea, Mohamed H H Roby, Hayam A A Mahdy, et al.
Future Medicinal Chemistry|February 25, 2025
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and <i>in silico</i> studiesReda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Computational Biology and Chemistry|September 27, 2024
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studiesHazem Elkady, Walid E Elgammal, Hazem A Mahdy, et al.
RSC Advances|November 7, 2024
Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive <i>in vitro</i> and <i>in silico</i> studyIbrahim H Eissa, Walid E Elgammal, Hazem A Mahdy, et al.
Chemical Biology & Drug Design|March 26, 2026
Thiadiazole-Derived VEGFR-2 Inhibitors: From Design to Anticancer EvaluationAisha A Alsfouk, Eslam B Elkaeed, Hazem Elkady, et al.
Environmental Pollution (Barking, Essex : 1987)|October 11, 2016
Infectious bacterial pathogens, parasites and pathological correlations of sewage pollution as an important threat to farmed fishes in EgyptMahmoud A Mahmoud, Mohamed Abdelsalam, Olfat A Mahdy, et al.
Chemical Biology & Drug Design|July 21, 2025
New Thiadiazole-Benzenesulfonamide Hybrids as Dual B-Raf/VEGFR-2 Inhibitors With Promising Anti-Hepatic Cancer ActivityAisha A Alsfouk, Hazem Elkady, Saber M Hassan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 28, 2021
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studiesHazem Elkady, Alaa Elwan, Hesham A El-Mahdy, et al.
Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
International Journal of Molecular Sciences|August 12, 2023
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide AnalogsReda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy, et al.
Plants (Basel, Switzerland)|February 26, 2022
Improvement of Selected Morphological, Physiological, and Biochemical Parameters of Roselle (<i>Hibiscus sabdariffa</i> L.) Grown under Different Salinity Levels Using Potassium Silicate and <i>Aloe saponaria</i> ExtractAlaa Idris Badawy Abou-Sreea, Mohamed H H Roby, Hayam A A Mahdy, et al.
Future Medicinal Chemistry|February 25, 2025
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and <i>in silico</i> studiesReda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, et al.
Pageof 20